| タイトル |
Clinical Characteristics and Treatment Outcomes of Autoimmune-Associated Hemophagocytic Syndrome in Adults
|
| 著者 |
Murakawa Yohko
|
| 収録物名 |
ARTHRITIS & RHEUMATOLOGY
|
| 巻 | 66 |
| 号 | 8 |
| 開始ページ | 2297 |
| 終了ページ | 2307 |
| 収録物識別子 |
ISSN 2326-5191
EISSN 2326-5205
|
| 言語 |
英語
|
| 資源タイプ | 学術雑誌論文 |
| 出版者 |
WILEY
|
| 発行日 | 2014-08 |
| アクセス権 | メタデータのみ |
| 関連情報 |
[DOI] 10.1002/art.38672
[PMID] 24756912
|
| 備考 | Dr. Kumakura has received speaking fees from Dainippon Sumitomo Pharma (less than $10,000). Dr. Murakawa has received speaking fees from Chugai Pharma, Eisai, Mitsubishi Tanabe Pharma, Pfizer, Astellas Pharma, Takeda Pharma, Janssen Pharma, Santen Pharma, Bristol-Myers Squibb, Ono Pharma, Kissei Pharma, Actelion Pharma, and AbbVie Japan and research grant support from Teijin Pharma, Astellas Pharma, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma, Chugai Pharma, Takeda Pharma, and Eisai (less than $10,000 each). |
